MARKET

TXG

TXG

10X Genomics, Inc.
NASDAQ
17.77
-0.38
-2.09%
After Hours: 17.80 +0.03 +0.17% 18:26 12/05 EST
OPEN
18.02
PREV CLOSE
18.15
HIGH
18.20
LOW
17.39
VOLUME
1.91M
TURNOVER
--
52 WEEK HIGH
20.34
52 WEEK LOW
6.78
MARKET CAP
2.25B
P/E (TTM)
-28.4366
1D
5D
1M
3M
1Y
5Y
1D
10x Genomics (TXG): Assessing Valuation After a 36% One-Month Share Price Rebound
Simply Wall St · 1d ago
3 Unprofitable Stocks with Questionable Fundamentals
Barchart · 2d ago
This Coca-Cola Femsa Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Tuesday
Benzinga · 4d ago
Teradyne upgraded, Circle Internet initiated: Wall Street’s top analyst calls
TipRanks · 4d ago
10x Genomics Cut to Equal-Weight From Overweight by Morgan Stanley
Dow Jones · 4d ago
10x Genomics Price Target Raised to $20.00/Share From $17.00 by Morgan Stanley
Dow Jones · 4d ago
Morgan Stanley Downgrades 10x Genomics to Equal-Weight, Raises Price Target to $20
Benzinga · 4d ago
10x Genomics assumed at Equal Weight from Overweight at Morgan Stanley
TipRanks · 4d ago
More
About TXG
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.

Webull offers 10X Genomics Inc stock information, including NASDAQ: TXG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TXG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TXG stock methods without spending real money on the virtual paper trading platform.